Effects of atipamezole, an α2-adrenergic antagonist, and somatostatin on xylazine-induced growth hormone release in calves

Endocrine Journal

Volumn 43, Issue 5, 1996, Pages 551-556

  Kasuya, Etsuko ^a   Hodate, Koichi ^b   Matsumoto, Mitsuto ^b   Sakaguchi, Minoru ^b   Hashizume, Tsutomu ^a   Kanematsu, Shigeto ^a  

^a IWATE UNIVERSITY   (Japan)

^b NATIONAL AGRICULTURAL RESEARCH CENTER FOR TOHOKU REGION   (Japan)

Author keywords

Atipamezole; Calves; GH; Xylazine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ATIPAMEZOLE; GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOSTATIN; XYLAZINE;

AREA UNDER THE CURVE; ARTICLE; CATTLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HYPERGLYCEMIA; HYPOINSULINEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RADIOIMMUNOASSAY;

EID: 0029961848     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.43.551     Document Type: Article

References (28)

1. Frohman LA, Downs TR, Chomczynski P (1992) Regulation of growth hormone secretion. Frontiers in Neuroendocrinology 13: 344-405.
2. Devesa J, Lima L, Tresguerres JAF (1992) Neuroendocrine control of growth hormone secretion in humans. Trends Endocrinol Metab 3: 175-183.
3. Knight AP (1980) Xylazine. J Am Vet Med Assoc 176: 454-455.
4. Greene SA, Thurmon JC (1988) Xylazine - A review of its pharmacology and use in veterinary medicine. J Vet Pharmacol Therap 11: 295-313.
5. Hampshire J, Altszuler N (1981) Clonidine or xylazine as provocative tests for growth hormone secretion in the dog. Am J Vet Res 42: 1073-1076.
6. Kasuya E, Hodate K, Matsumoto M, Sakaguchi M, Hashizume T, Kanematsu S (1996) The effects of xylazine on plasma concentrations of growh hormone, insulin-like growth factor-I, glucose and insulin in calves. Endocr J 43: 145-149.
7. 2-adrenergic receptors regulating insulin release. Endocrinology 109: 825-829.
8. Brockman RP (1981) Effect of xylazine on plasma glucose, glucagon and insulin concentrations in sheep. Res Vet Sci 30: 383-384.
9. Eichner RD, Prior RL, Kvasnicka WG (1979) Xylazine-induced hyperglycemia in beef cattle. Am J Vet Res 40: 127-129.
10. Symonds HW (1976) The effect of xylazine upon hepatic glucose production and blood flow rate in the lactating dairy cow. Vet Rec 99: 234-236.
11. Symonds HW, Mallinson CB (1978) The effect of xylazine and xylazine followed by insulin on blood glucose and insulin in the dairy cow. Vet Rec 102: 27-29.
12. Wong WC, Gluchowski C (1995) A concise synthesis of atipamezole. Synthesis 1995(2): 139-140.
13. Nishimura R, Kim H, Matsunaga S, Sakaguchi M, Sasaki N, Tamura H, Takeuchi A (1992) Antagonism of medetomidine sedation by atipamezole in pigs. J Vet Med Sci 54: 1237-1240.
14. Johke T (1978) Effect of TRH on circulating growth hormone, prolactin and triiodothyronine levels in the bovine. Endocrinol Japon 25: 19-26.
15. Wakabayashi K (1984) Arrangement of Experimental Data. Baihukan, Tokyo, 44-57, 90-133.
16. 1 in conscious male rats. Neuroendocrinology 38: 1-5.
17. Miki N, Ono M, Shizume K (1984) Evidence that opiatergic and α-adrenergic mechanisms stimulate rat growth hormone release via growth hormone-releasing factor (GRF). Endocrinology 114: 1950-1952.
18. Kabayama Y, Kato Y, Murakami Y, Tanaka H, Imura H (1986) Stimulation by alpha-adrenergic mechanisms of the secretion of growth hormone-releasing factor (GRF) from perifused rat hypothalamus. Endocrinology 119: 432-434.
19. Gil-Ad I, Laron Z, Koch Y (1991) Effect of acute and chronic administration of clonidine on hypothalamic content of growth hormone-releasing hormone and somatostatin in the rat. J Endocrinol 131: 381-385.
20. Lima L, Arce V, Tresguerres JAF, Devesa J (1993) Clonidine potentiates the growth hormone (GH) responese to GH releasing-hormone in norepinephrine synthesis-inhibited rats: Evidence for an alpha-2-adrenergic control of hypothalamic release of somatostatin. Neuroendocrinology 57: 1155-1160.
21. Lanzi R, Lapointe M, Gurd W, Tannenbaum GS (1994) Evidence for a primary involvement of somatostatin in clonidine-induced growth hormone release in conscious rats. J Endocrinol 141: 259-266.
22. Arce V, Barros MG, Vara E, Lima L, Tresguerres JAF, Devesa J (1995) Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats. Neuroendocrinology 61: 552-558.
23. 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. J Clin Endocrinol Metab 73: 251-256.
24. Magnan E, Cataldi M, Guillaume V, Mazzocchi L, Dutour A, Razafindraibe H, Sauze N, Renard M, Oliver C (1994) Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep. Endocrinology 134: 562-567.
25. Miki N, Ono M, Shizume K (1988) Withdrawal of endogenous somatostatin induces secretion of growth hormone-releasing factor in rats. J Endocrinol 117: 245-252.
26. Magnan E, Cataldi M, Guillaume V, Conte Devolx B, Graziani N, Figaroli JC, Thomas F, Chihara K, Oliver C (1992) Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long acting somatostatin analog, in rats. Life Sci 51: 831-838.
27. Hsu WH (1988) Yohimbine increases plasma insulin concentrations and reverses xylazine-induced hypoinsulinemia in dogs. Am J Vet Res 49: 242-244.
28. Muller BE (1987) Neural control of somatotropic function. Physiol Rev 67: 962-1053.